참고문헌
- Raje N, Anderson K. Thalidomide: a revival story. N Engl J Med 1999;341:1606-1609. https://doi.org/10.1056/NEJM199911183412110
- Figg WD, Dahut W, Duray P, et al. A randomized phase II trial of thalidomide, an angiogenesis inhibitor, in patients with androgen-independent prostate cancer. Clin Cancer Res 2001;7:1888-1893.
- Epler GR. Drug-induced bronchiolitis obliterans organizing pneumonia. Clin Chest Med 2004;25:89-94. https://doi.org/10.1016/S0272-5231(03)00140-0
- Camus P, Kudoh S, Ebina M. Interstitial lung disease associated with drug therapy. Br J Cancer 2004;91 Suppl 2:S18-S23.
- Feaver AA, McCune DE, Mysliwiec AG, Mysliwiec V. Thalidomide-induced organizing pneumonia. South Med J 2006;99:1292-1294. https://doi.org/10.1097/01.smj.0000233182.06540.00
- Iguchi T, Sakoda M, Chen CK, et al. Interstitial pneumonia during treatment with thalidomide in a patient with multiple myeloma. Rinsho Ketsueki 2004;45:1064-1066.
- Carrion Valero F, Bertomeu Gonzalez V. Lung toxicity due to thalidomide. Arch Bronconeumol 2002;38:492-494. https://doi.org/10.1016/S0300-2896(02)75272-1
- Behrens RJ, Gulley JL, Dahut WL. Pulmonary toxicity during prostate cancer treatment with docetaxel and thalidomide. Am J Ther 2003;10:228-232. https://doi.org/10.1097/00045391-200305000-00011
- Onozawa M, Hashino S, Sogabe S, et al. Side effects and good effects from new chemotherapeutic agents. Case 2: thalidomideinduced interstitial pneumonitis. J Clin Oncol 2005;23:2425-2426. https://doi.org/10.1200/JCO.2005.04.054
피인용 문헌
- Antineoplastic therapy-induced pulmonary toxicity vol.13, pp.8, 2013, https://doi.org/10.1586/14737140.2013.817684
- Thalidomide-induced bronchiolitis obliterans organizing pneumonia in a patient with multiple myeloma vol.30, pp.4, 2010, https://doi.org/10.4103/1319-2442.265477